방사선종양학

본문글자크기
  • [Acta Oncol.] Treatment Outcomes of Patients With Salivary Duct Carcinoma Undergoing Surgery and Postoperative Radiotherapy

    [Acta Oncol.] Treatment Outcomes of Patients With Salivary Duct Carcinoma Undergoing Surgery and Postoperative Radiotherapy

    연세의대, 경북대 / 이동수,이창걸*, 강민규*

  • 출처
    Acta Oncol.
  • 등재일
    2020 May
  • 저널이슈번호
    59(5):565-568. doi: 10.1080/0284186X.2020.1730005. Epub 2020 Feb 21.
  • 내용

    바로가기  >

    No abstract

    This study aimed to elucidate the treatment outcomes and the patterns of failure of SDC treated with surgery and PORT, among patients enrolled in the multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG) 13-09.

    In summary, the present study demonstrated that surgery followed by PORT was effective in LRC, but not in DC, in major salivary gland SDC. Optimization of radical surgery, proper RT field design based on this study’s results, and application of novel systemic agents to minimize DM would be indispensable for future SDC treatment.

     

     

    Affiliations

    Dong Soo Lee  1 , Chang Geol Lee  2 , Ki Chang Keum  2 , Seung Yeun Chung  2 , Taehyung Kim  2 , Hong-Gyun Wu  3   4   5 , Jin Ho Kim  3 , Myung-Whun Sung  6 , Soon-Hyun Ahn  6 , Kwan Ho Cho  7 , Ki Mun Kang  8 , Young-Taek Oh  9 , Jin Hee Kim  10 , Min Kyu Kang  11
    1 Department of Radiation Oncology, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
    2 Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea.
    3 Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, South Korea.
    4 Cancer Research Institution, Seoul National University College of Medicine, Seoul, South Korea.
    5 Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, South Korea.
    6 Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul, South Korea.
    7 Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
    8 Department of Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Jinju, South Korea.
    9 Department of Radiation Oncology, Ajou University School of Medicine, Suwon, South Korea.
    10 Department of Radiation Oncology, Keimyung University, School of Medicine, Daegu, South Korea.
    11 Department of Radiation Oncology, School of Medicine, Kyungpook National University, Daegu, South Korea.

  • 연구소개
    본 연구는 Major Salivary Gland Cancer에 대한 다기관 연구(KROG 13-09)에 등록된 수술 후 방사선치료를 받은 Salivary Gland Duct Carcinoma 환자를 대상으로 예후 및 재발에 대한 예후 인자를 분석하였습니다. 다기관에서 모집된 환자의 수가 27명으로 적기는 하지만, 생존율 및 재발양상은 기존의 연구와 비슷한 것을 확인하였습니다. 추가적으로, 경부림프절에 대한 방사선치료 범위를 제안하기 위해, 수술 후 확인된 경부림프절의 전이 상태과 방사선치료 범위에 따른 경부림프절의 재발양상을 분석였습니다. 그 결과, pN0 or pNx인 경우는 수술후 방사선치료시 ipsilateral upper neck만 조사하면 충분할 수 있고, pN+인 경우는 whole neck을 치료할 필요가 있음을 확인하였습니다. 다만, 본 연구에 포함된 환자수가 적기 때문에, 더 많은 환자를 대상으로한 추가 연구가 필요합니다.
  • 덧글달기
    덧글달기
       IP : 3.135.227.135

    등록